NCT05672251: An ongoing trial by City of Hope Medical Center
This trial is ongoing. It must report results 10 months, 4 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05672251 |
|---|---|
| Title | A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 2, 2024 |
| Completion date | April 7, 2026 |
| Required reporting date | April 7, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 11, 2026 |
| Days late | None |